Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2432 (LINC02432)

Target
LINC02432
Molecular classification
Other, Long non-coding RNA (lncRNA), competing endogenous RNA (ceRNA)
01

Overview

Long intergenic non-protein coding RNA 2432 (LINC02432) is a long non-coding RNA implicated in the regulation of cancer cell metabolism, particularly in pancreatic adenocarcinoma. As part of a regulatory axis with miR-98-5p and HK2, LINC02432 promotes glycolysis and suppresses ferroptosis, thereby enhancing tumor cell proliferation and survival. Its expression is correlated with immune infiltration and tumor mutation burden, highlighting its role as a risk stratification marker and potential therapeutic target. Elevated LINC02432 suggests a worse prognosis, and patients with high expression may show increased sensitivity to certain kinase inhibitors[2][4].

Other names
LINC02432long intergenic non-coding RNA 2432
02

Mechanism of action

Acts as a competing endogenous RNA (ceRNA) by sponging miR-98-5p, leading to upregulation of HK2 and enhanced glycolytic activity in cancer cells; disruption of ferroptosis; modulation of immune cell infiltration and chemokine expression

03

Biological functions

Regulation of glycolysisInhibition of ferroptosisRegulation of cell proliferationImmune modulation (via immune cells and chemokines)Regulation of tumor mutation burden
04

Disease associations

Cancer (notably pancreatic adenocarcinoma)Potential biomarker and therapeutic target for cancer prognosis and treatment
05

Safety considerations

None specifically reported, but targeting long non-coding RNAs may pose challenges related to specificity and potential off-target effects
06

Interacting drugs

EGFR inhibitors

2 more in the full profile.

07

Biomarkers

High LINC02432 expression (prognostic biomarker for poor survival in pancreatic adenocarcinoma)HK2 protein levelsmiR-98-5p levelsceRNA network risk scoretumor mutation burden

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2432 (LINC02432).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2432 (LINC02432).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call